Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA1/2 mutation carriers & risk reducing mastectomy: Who undergoes surgery and potential benefits.

American journal of surgery - 1 Jan 2024

Record Sydney M, Thomas Samantha M, Ntowe Koumani, Chiba Akiko, Plichta Jennifer K

Abstract excerpt

BACKGROUND: Risk-reducing mastectomy (RRM) is the most effective breast cancer risk-reduction strategy in BRCA1/2 mutation carriers. We examined factors associated with RRM and its relationship with overall survival (OS). METHODS: Patients aged 18-80y at diagnosis of their BRCA1/2 mutation were selected from our institutional database and stratified by RRM receipt. Differences were tested; unadjusted OS was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Heterozygote

Share to Mastectomy

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 37827871
DOI: 10.1016/j.amjsurg.2023.10.011
PMCID: PMC10842097

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA1/2 mutation carriers & risk reducing mastectomy: Who undergoes surgery and potential benefits.PMID 37827871Read ↗

Risk reducing mastectomy in Norwegian BRCA1/2 carriers.Semantic proximity Read ↗

Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.Semantic proximity Read ↗

Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral.Semantic proximity Read ↗

Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution.Semantic proximity Read ↗

Risk management decisions in women with BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.Semantic proximity Read ↗

When to Consider Risk-Reducing Mastectomy in BRCA1/BRCA2 Mutation Carriers with Advanced Stage Ovarian Cancer: a Case Study Illustrating the Genetic Counseling Challenges.Semantic proximity Read ↗

Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers.Semantic proximity Read ↗

Survival Outcomes With or Without Risk-Reducing Mastectomy in BRCA1 and BRCA2 Pathogenic Variant Carriers.Semantic proximity Read ↗

Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer.Semantic proximity Read ↗

Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers.Semantic proximity Read ↗

Impact of breast surgical procedure on survival in BRCA mutated patients with invasive breast cancer: Mastectomy versus conservative treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.